|
IX |
25 |
Three primary brain divisions visible in open neural folds |
|
X |
28 |
Optic sulcus visible; neural tube begins to fuse |
|
XI |
29 |
Closure of rostral neuropore is complete |
|
XII |
30 |
Infundibular hypothalamus indicated by relation to Rathke’s
pouch |
|
XIII |
32 |
Mammillary recess identified |
|
XIV |
33 |
Hypothalamic cell cord identified |
|
XV |
36 |
Appearance of mammillary nuclei and MTT fibres |
|
XVII |
41 |
Supra- and inframammillary recesses define the mammillary area |
CS = Carnegie stage of development;
DPC = approximate days post-conception;
MTT = mammillotegmental tract.
Developmental biology of the hypothalamus
The relationship between the pituitary gland and hypothalamus in
development has been clarified by laboratory animal evidence
showing that the whole of the pituitary (including the anterior
pituitary precursor Rathke’s pouch, formerly thought of as an
epithelial structure) is derived from the anterior neural ridge
[55], and that the adjacent neural plate gives rise to the
hypothalamus [40]. Some cells of the hypothalamus proper arise in
structures of anterior neural ridge origin but take an
extracerebral route to their final destination [56];
luteinising-hormone-releasing hormone – (LHRH) producing
cells, for example, originate in the olfactory placode and then
migrate to the septal region, anterior hypothalamus and median
eminence [57].
Genetic mechanisms that underlie hypothalamic development are
beginning to be unravelled. As reviewed by Michaud, the program of
development progresses from induction and patterning of the
hypothalamus by the axial mesendoderm, to the differentiation of
specific hypothalamic nuclei [58]. At present, considerably more is
known about development of the hypothalamic-pituitary axis than
about other hypothalamic structures, just as knowledge of the
function of the hypothalamus is more advanced in relation to
neurendocrine aspects.
Sonic hedgehog protein (SHH) is a concentration-dependent
morphogen that is produced by the axial mesendoderm and plays a
crucial role in dorso-ventral patterning of the neuraxis along its
length, by regulating the expression of a large number of
homeodomain proteins [59]. It is the major known factor in
ventralisation of the developing forebrain and its expression by
the underlying prechordal plate is a requirement for appearance of
the hypothalamic anlage, and splitting of the eye field into two
[60]. SHH-dependent Nkx-2.1 expression [61] demarcates the
primordial hypothalamus as early as the three-somite stage in mice
(equivalent Carnegie stage IX) [44], and is required for the normal
development of the anterior pituitary as well as many hypothalamic
nuclei, including those in the mammillary region [62]. In addition,
SHH appears to influence both proliferation and cell-type
determination in the developing pituitary gland [63].
In the hypothalamic-pituitary axis, differentiation of specific
cell types progresses in an orderly fashion, controlled by a
hierarchy of transcription factors expressed in a spatially and
temporally restricted sequence. Factors involved in pituitary
specification include Rpx (Rathke’s pouch homeobox), Six3, Pax6,
Lhx3, Ptx1, Pit-1 and SF-1. Development of cell phenotype in
the supraoptic, paraventricular, periventricular and arcuate nuclei
is regulated by factors including Sim1, Arnt2, Otp, Brn2, and Gsh1.
Treier and Rosenfeld reviewed the topic of hypothalamic-pituitary
co-development in detail [64]; more recent information concerning
neurendocrine hypothalamic differentiation was summarised by
Acampora et al. [65].
Although the precise mechanisms of hypothalamic nuclear
specification are unknown, the number of transcription factors
implicated continues to increase. These include: Fhx5, essential
for mammillary body development [66]; Pax6, required for
mammillothalamic tract development and axon path finding [67];
Wnt8b, expressed in the mammillary region of human embryos [68];
and SF-1, necessary for normal development of the ventromedial
nucleus [69]. Further study of these and other factors may answer
questions about normal and abnormal hypothalamic development.
Development of hypothalamic hamartomas
The embryological origin of HH has not been determined.
Histological examination of hamartoma biopsy material from patients
with epilepsy has shown a mixture of mature neuronal and glial
cells [70], with some myelinated fibres present [71] and an overall
resemblance to normal hypothalamic grey matter [32]. Hamartomas
associated with precocious puberty have been shown to contain
neurosecretory granules and immunoreactive staining with antibodies
to LHRH [72], including one child with the combination of gelastic
seizures and precocious puberty [73]. In two other cases with
precocious puberty alone, LHRH was not found, but transforming
growth factor alpha and its receptor were present [74]. A detailed
study of HH cell characteristics with respect to normal
hypothalamic nuclear cytoarchitecture and immunohistochemistry in a
large series is awaited.
A relatively small number of potentially harmful prenatal
exposures have been accepted as causing brain malformation, with
some known to produce specific malformations of cortical
development (MCD). Examples of the latter include viral infections
such as cytomegalovirus, ionising radiation, medications such as
isotretinoin, alcohol, illicit drugs such as cocaine, and toxins
such as methylmercury [75-78]. Only two case-control studies of MCD
are reported in the literature. The first involved mainly adult
epilepsy surgery patients, comparing those with and without MRI
evidence of MCD, and found that mothers of patients with MCD were
more likely to have been exposed to injury, medication, infection,
or irradiation during pregnancy than were mothers of patients
without MCD [79]. The second study found a higher rate of antenatal
maternal exposure to medication, alcohol and potential toxins among
paediatric epilepsy surgery patients with histological evidence of
MCD, as compared to age-matched, neurologically normal controls
[80]. Together, these provide some evidence for the importance of
environmental factors in the pathogenesis of MCD, although neither
study included patients with HH. Potential environmental
antecedents to the development of HH deserve some attention and,
given the rarity of the malformation, a case-control study would be
appropriate.
There are a number of multiple congenital anomaly syndromes in
which HH have been described, but in only one of
these – Pallister-Hall syndrome (PHS) – is the
HH a characteristic feature and required for the diagnosis of an
index case [81]. Along with central polydactyly, associated
malformations in PHS include dysplastic nails, pituitary hypoplasia
or dysfunction, bifid epiglottis and imperforate anus [82].
Autosomal-dominant transmission of PHS is described [83], and in
some families a mutation in the Gli3 gene on chromosome
7p13 is present [84]. Gli proteins are zinc-finger
transcription factors that act downstream of SHH-signalling to
regulate target-gene expression [85]. As discussed by Michaud, the
mechanism by which Gli3 frameshift mutation leads to HH formation
is currently unknown, but may be related to either gain or loss of
normal Gli3 function as an inhibitor of SHH-signalling [58].
One case report of the cytogenetic evaluation of an HH in a
patient with PHS, cited by Biesecker and Graham [82], showed the
absence of chromosome 17 in two of 43 cells, but no
similar studies on HH tissue are described. One patient with HH and
microphthalmia, but not polydactyly, was found to have an
unbalanced chromosome 7 translocation that did not involve the
Gli3 locus [86]. Other entities, probably distinct from PHS, in
which HH have been reported include the McKusick-Kaufman syndrome
[87], Bardet-Biedl syndrome [88], oral-facial-digital syndrome type
6 [89] and Waardenburg syndrome [90]; of interest in relation
to the first two conditions is that one form of Bardet-Biedl
syndrome has a mutation in the gene associated with
McKusick-Kaufman syndrome (MKKS) on chromosome 20p12 [91]. It
is quite possible that genetic factors in the development of
syndrome-associated HH could play a part in the development of
sporadic, non-syndrome-associated HH, however no clinical or
molecular genetic studies of such patients have been reported.
Cytogenetic and molecular genetic evaluation of biopsied HH
material might also prove rewarding in this respect.
It is likely that both the anatomical position and the intrinsic
epileptogenicity of HH associated with seizures together contribute
to the various neurological disorders associated with HH [92].
Appreciation of the normal functional anatomy of the hypothalamus,
the structural relationship and connectivity between HH and
adjacent hypothalamic nuclei and fibre pathways, and visualisation
of this with high-quality MRI is necessary for understanding the
clinical manifestations of HH and in predicting potential
complications that may result from HH surgery. The anatomo-clinical
correlation may contribute to questions about the mechanisms of
epileptogenesis, reasons for cognitive deficits and the nature of
behavioural and psychiatric disturbance.
While the cause of sporadic HH development is not known, there
is considerable effort currently invested in understanding normal
development of the human hypothalamus, and this will undoubtedly
contribute to a better appreciation of abnormal development. The
most promising avenue for further investigation in this respect is
the exploration of the mechanisms of HH development in genetically
determined, syndrome-associated HH.
Acknowledgements
I wish to acknowledge Dr A. Simon Harvey who encouraged this work,
facilitated its presentation at the symposium, and reviewed the
manuscript.
This work was supported by a Postgraduate Research Scholarship
from the National Health and Medical Research Council of Australia
and by a Faculty Research Scholarship from the University of
Melbourne, Faculty of Medicine, Dentistry and Health
Sciences. n
References
1. List CF, Dowman CE, Bagchi BK, et al.
Posterior hypothalamic hamartomas and gangliogliomas causing
precocious puberty. Neurology 1958; 8: 164-74.
2. Berkovic SF, Andermann F, Melanson D, et
al. Hypothalamic hamartomas and ictal laughter: evolution of a
characteristic epileptic syndrome and diagnostic value of magnetic
resonance imaging. Ann Neurol 1988; 23: 429-39.
3. Deonna T, Ziegler AL. Hypothalamic hamartoma,
precocious puberty and gelastic seizures: a special model of
epileptic’ developmental disorder. Epileptic Disord 2000; 2:
33-7.
4. Frattali CM, Liow K, Craig GH et al.
Cognitive deficits in children with gelastic seizures and
hypothalamic hamartoma. Neurology 2001; 57: 43-6.
5. Weissenberger AA, Dell ML, Liow K, et al.
Aggression and psychiatric comorbidity in children with
hypothalamic hamartomas and their unaffected siblings. J Am Acad
Child Adolesc Psychiatry 2001; 40: 696-703.
6. Nauta WJH, Haymaker W. Hypothalamic nuclei and
fiber connections. In: Haymaker W, Anderson E, Nauta WJH. The
hypothalamus. Springfield: Thomas, 1969: 136-209.
7. Truex RC, Carpenter MB. The diencephalon and
corpus striatum. In: Truex RC, Carpenter MB. Human
Neuroanatomy. Baltimore: Williams and Wilkins, 1964:
379-442.
8. Crosby EC, Showers MJC. Comparative anatomy of
the preoptic and hypothalamic areas. In: Haymaker W, Anderson E,
Nauta WJH. The hypothalamus. Springfield: Thomas, 1969:
61-135.
9. Braak H, Braak E. Anatomy of the human
hypothalamus (chiasmatic and tuberal region). Prog Brain Res
1992; 93: 3-14.
10. Kuhlenbeck H, Christ JF. Derivation and
boundaries of the hypothalamus, with atlas of hypothalamic grisea.
In: Haymaker W, Anderson E, Nauta WJH. The hypothalamus.
Springfield: Thomas, 1969: 13-60.
11. Swanson LW. The neuroanatomy revolution of the
1970s and the hypothalamus. Brain Res Bull 1999; 50:
397.
12. Swaab DF. Development of the human hypothalamus.
Neurochem Res 1995; 20: 509-19.
13. Saper CB. Hypothalamic connections with the
cerebral cortex. Prog Brain Res 2000; 126: 39-48.
14. Holman SD, Janus C. Laterally asymmetrical cell
number in a sexually dimorphic nucleus in the gerbil hypothalamus
is correlated with vocal emission rates. Behav Neurosci
1998; 112: 979-90.
15. Moore RY. The organization of the human
circadian timing system. Prog Brain Res 1992; 93:
99-115.
16. Nolte J. Drives, emotions and memories: the
hypothalamus and limbic system. The human brain: an introduction
to its functional anatomy. St. Louis: Mosby, 1999: 537-63.
17. Meyers RD. Temperature regulation: neurochemical
systems in the hypothalamus. In: Haymaker W, Anderson E, Nauta WJH.
The hypothalamus. Springfield: Thomas, 1969: 506-23.
18. MacLean PD. The hypothalamus and emotional
behavior. In: Haymaker W, Anderson E, Nauta WJH. The
hypothalamus. Springfield: Thomas, 1969: 659-78.
19. Bard P. A diencephalic mechanism for the
expression of rage with special reference to the sympathetic
nervous system. Am J Physiol 1928; 84: 490-515.
20. Foerster O, Gagel O. Ein fall von ependymcyste
des III. ventrikels. Ein beitrag zur frage der beziehungen
psychischer störungen zum hirnstamm. Z ges Neurol Psychiatr
1933; 149: 312-44.
21. Martin JP. Fits of laughter (sham mirth) in
organic cerebral disease. Brain 1950; 73: 453-64.
22. Arroyo S, Lesser RP, Gordon B et al.
Mirth, laughter and gelastic seizures. Brain 1993; 116 (Pt
4): 757-80.
23. Munari C, Kahane P, Francione S et al.
Role of the hypothalamic hamartoma in the genesis of gelastic fits
(a video-stereo-EEG study).Electroencephalogr Clin
Neurophysiol 1995; 95: 154-60.
24. Kuzniecky R, Guthrie B, Mountz J et al.
Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic
epilepsy. Ann Neurol 1997; 42: 60-7.
25. Papez JW. A proposed mechanism of emotion.
Arch Neurol Psychiatr 1937; 38: 725-43.
26. Damasio AR, Van Hoesen GW, Tranel D.
Pathological correlates of amnesia and the anatomical basis of
memory. In: Apuzzo MLJ. Surgery of the third ventricle.
Baltimore: Williams and Wilkins, 1998: 187-204.
27. Adams RD, Victor M. Diseases of the nervous
system due to nutritional deficiency. Principles of
Neurology. New York: McGraw-Hill, 1989: 820-45.
28. Garcia-Bengochea F, Friedman WA. Persistent
memory loss following section of the anterior fornix in humans. A
historical review. Surg Neurol 1987; 27: 361-4.
29. Gaffan D, Gaffan EA. Amnesia in man following
transection of the fornix. A review. Brain 1991; 114 (Pt 6):
2611-8.
30. Zola-Morgan S, Squire LR, Amaral DG. Lesions of
the hippocampal formation but not lesions of the fornix or the
mammillary nuclei produce long-lasting memory impairment in
monkeys. J Neurosci 1989; 9: 898-913.
31. Hodges JR, Carpenter K. Anterograde amnesia with
fornix damage following removal of IIIrd ventricle colloid cyst.
J Neurol Neurosurg Psychiatry 1991; 54: 633-8.
32. Boyko OB, Curnes JT, Oakes WJ et al.
Hamartomas of the tuber cinereum: CT, MR, and pathologic findings.
AJNR Am J Neuroradiol 1991; 12: 309-14.
33. Arita K, Ikawa F, Kurisu K, et al. The
relationship between magnetic resonance imaging findings and
clinical manifestations of hypothalamic hamartoma. J
Neurosurg 1999; 91: 212-20.
34. Valdueza JM, Cristante L, Dammann O, et
al. Hypothalamic hamartomas: with special reference to gelastic
epilepsy and surgery. Neurosurgery 1994; 34: 949-58.
35. Miller MJ, Mark LP, Yetkin FZ, et al.
Imaging white matter tracts and nuclei of the hypothalamus: an MR-
anatomic comparative study. AJNR Am J Neuroradiol 1994; 15:
117-21.
36. Saeki N, Sunami K, Kubota M, et al.
Heavily T2-weighted MR imaging of white matter tracts in the
hypothalamus: normal and pathologic demonstrations. AJNR Am J
Neuroradiol 2001; 22: 1468-75.
37. Muller F, O’Rahilly R. The timing and sequence
of appearance of neuromeres and their derivatives in staged human
embryos. Acta Anat (Basel) 1997; 158: 83-99.
38. Kuhlenbeck H, Haymaker W. The derivatives of the
hypothalamus in the human brain; their relation to the
extrapyramidal and autonomic nervous system. Milit Surg
1949; 105: 26.
39. Kuhlenbeck H. Overall morphologic pattern.
The central nervous system of vertebrates: a general survey of
its comparative anatomy with an introduction to the pertinent
fundamental biologic and logical concepts. Basel: S.Karger,
1973.
40. Couly G, Le Douarin NM. The fate map of the
cephalic neural primordium at the presomitic to the 3-somite stage
in the avian embryo. Development 1988; 103 Suppl:
101-13.
41. Eagleson GW, Harris WA. Mapping of the
presumptive brain regions in the neural plate of Xenopus laevis.
J Neurobiol 1990; 21: 427-40.
42. Puelles L, Rubenstein JL. Expression patterns of
homeobox and other putative regulatory genes in the embryonic mouse
forebrain suggest a neuromeric organization. Trends Neurosci
1993; 16: 472-9.
43. Rubenstein JL, Martinez S, Shimamura K, et
al. The embryonic vertebrate forebrain: the prosomeric model.
Science 1994; 266: 578-80.
44. Shimamura K, Hartigan DJ, Martinez S, et
al. Longitudinal organization of the anterior neural plate and
neural tube. Development 1995; 121: 3923-33.
45. Puelles L. Brain segmentation and forebrain
development in amniotes. Brain Res Bull 2001; 55:
695-710.
46. Hall JG, Pallister PD, Clarren SK et al.
Congenital hypothalamic hamartoblastoma, hypopituitarism,
imperforate anus and postaxial polydactyly – a new
syndrome? Part I: clinical, causal, and pathogenetic
considerations. Am J Med Genet 1980; 7: 47-74.
47. Clarren SK, Alvord EC, Jr., Hall JG. Congenital
hypothalamic hamartoblastoma, hypopituitarism, imperforate anus,
and postaxial polydactyly – a new syndrome? Part II:
Neuropathological considerations. Am J Med Genet 1980; 7:
75-83.
48. Muller F, O’Rahilly R. The first appearance of
the neural tube and optic primordium in the human embryo at stage
10. Anat Embryol (Berl) 1985; 172: 157-69.
49. Muller F, O’Rahilly R. The development of the
human brain, the closure of the caudal neuropore, and the beginning
of secondary neurulation at stage 12. Anat Embryol (Berl)
1987; 176: 413-30.
50. Muller F, O’Rahilly R. The development of the
human brain from a closed neural tube at stage 13. Anat Embryol
(Berl) 1988; 177: 203-24.
51. Muller F, O’Rahilly R. The development of the
human brain, including the longitudinal zoning in the diencephalon
at stage 15. Anat Embryol (Berl) 1988; 179: 55-71.
52. Muller F, O’Rahilly R. The human brain at stage
17, including the appearance of the future olfactory bulb and the
first amygdaloid nuclei. Anat Embryol (Berl) 1989; 180:
353-69.
53. O’Rahilly R, Muller F. The embryonic human
brain: an atlas of developmental stages. New York: Wiley-Liss,
1994.
54. O’Rahilly R, Muller F. Minireview: summary of
the initial development of the human nervous system.
Teratology 1999; 60: 39-41.
55. Kawamura K, Kikuyama S. Evidence that hypophysis
and hypothalamus constitute a single entity from the primary stage
of histogenesis. Development 1992; 115: 1-9.
56. Kawamura K, Kikuyama S. Morphogenesis of the
hypothalamus and hypophysis: their association, dissociation and
reassociation before and after “Rathke”. Arch Histol Cytol
1998; 61: 189-98.
57. Schwanzel-Fukuda M. Origin and migration of
luteinizing hormone-releasing hormone neurons in mammals.
Microsc Res Tech 1999; 44: 2-10.
58. Michaud JL. The developmental program of the
hypothalamus and its disorders. Clin Genet 2001; 60:
255-63.
59. Marti E, Bovolenta P. Sonic hedgehog in CNS
development: one signal, multiple outputs. Trends Neurosci
2002; 25: 89-96.
60. Pera EM, Kessel M. Patterning of the chick
forebrain anlage by the prechordal plate. Development 1997;
124: 4153-62.
61. Pabst O, Herbrand H, Takuma N, et al.
NKX2 gene expression in neuroectoderm but not in mesendodermally
derived structures depends on sonic hedgehog in mouse embryos.
Dev Genes Evol 2000; 210: 47-50.
62. Kimura S, Hara Y, Pineau T, et al. The
T/ebp null mouse: thyroid-specific enhancer-binding protein is
essential for the organogenesis of the thyroid, lung, ventral
forebrain, and pituitary. Genes Dev 1996; 10: 60-9.
63. Treier M, O’Connell S, Gleiberman A, et
al. Hedgehog signaling is required for pituitary gland
development. Development 2001; 128: 377-86.
64. Treier M, Rosenfeld MG. The
hypothalamic-pituitary axis: co-development of two organs. Curr
Opin Cell Biol 1996; 8: 833-43.
65. Acampora D, Postiglione MP, Avantaggiato V,
et al. Progressive impairment of developing neuroendocrine
cell lineages in the hypothalamus of mice lacking the Orthopedia
gene. Genes Dev 1999; 13: 2787-800.
66. Wehr R, Mansouri A, de Maeyer T et al.
Fkh5-deficient mice show dysgenesis in the caudal midbrain and
hypothalamic mammillary body. Development
1997;124:4447-56.
67. Valverde F, Garcia C, Lopez-Mascaraque L, et
al. Development of the mammillothalamic tract in normal and
Pax-6 mutant mice. J Comp Neurol 2000; 419:
485-504.
68. Lako M, Lindsay S, Bullen P, et al. A
novel mammalian wnt gene, WNT8B, shows brain-restricted expression
in early development, with sharply delimited expression boundaries
in the developing forebrain. Hum Mol Genet 1998; 7:
813-22.
69. Dellovade TL, Young M, Ross EP, et al.
Disruption of the gene encoding SF-1 alters the distribution
of hypothalamic neuronal phenotypes. J Comp Neurol 2000;
423: 579-89.
70. Rosenfeld JV, Harvey AS, Wrennall J, et
al. Transcallosal resection of hypothalamic hamartomas, with
control of seizures, in children with gelastic epilepsy.
Neurosurgery 2001; 48: 108-18.
71. Paillas JE, Roger J, Toga M, et al.
Hamartome de l’hypothalmus: étude clinique, radiologique,
histologique: résultats de l’exèrèse. Rev Neurol (Paris)
1969; 120: 177-94.
72. Judge DM, Kulin HE, Page R, et al.
Hypothalamic hamartoma: a source of luteinizing-hormone-releasing
factor in precocious puberty. N Engl J Med 1977; 296:
7-10.
73. Culler FL, James HE, Simon ML, et al.
Identification of gonadotropin-releasing hormone in neurons of a
hypothalamic hamartoma in a boy with precocious puberty.
Neurosurgery 1985; 17: 408-12.
74. Jung H, Carmel P, Schwartz MS et al. Some
hypothalamic hamartomas contain transforming growth factor alpha, a
puberty-inducing growth factor, but not luteinizing
hormone-releasing hormone neurons. J Clin Endocrinol Metab
1999; 84: 4695-701.
75. Choi BH. The effects of methylmercury on the
developing brain. Prog Neurobiol 1989; 32: 447-70.
76. Hayward JC, Titelbaum DS, Clancy RR, et
al. Lissencephaly-pachygyria associated with congenital
cytomegalovirus infection. J Child Neurol 1991; 6:
109-14.
77. Jones KL. Smith’s recognizable patterns of
human malformation. 5th ed. Philadelphia: W.B. Saunders,
1997.
78. Volpe JJ. Teratogenic effects of drugs and
passive addiction. Neurology of the newborn. Philadelphia:
W.B. Saunders, 2001: 859-98.
79. Palmini A, Andermann E, Andermann F. Prenatal
events and genetic factors in epileptic patients with neuronal
migration disorders. Epilepsia 1994; 35: 965-73.
80. Dean P, Harvey AS, Bean J, et al.
Antecedents of developmental neuropathology: a case-control study
in surgically-treated children with intractable partial epilepsy.
Epilepsia 1996; 37: S104. (Abstract)
81. Biesecker LG, Abbott M, Allen J, et al.
Report from the workshop on Pallister-Hall syndrome and related
phenotypes. Am J Med Genet 1996; 65: 76-81.
82. Biesecker LG, Graham JM, Jr. Pallister-Hall
syndrome. J Med Genet 1996;33:585-9.
83. Topf KF, Kletter GB, Kelch RP, et al.
Autosomal dominant transmission of the Pallister-Hall syndrome.
J Pediatr 1993; 123: 943-6.
84. Kang S, Graham JM, Jr., Olney AH, et al.
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall
syndrome. Nat Genet 1997; 15: 266-8.
85. Villavicencio EH, Walterhouse DO, Iannaccone PM.
The sonic hedgehog-patched-gli pathway in human development and
disease. Am J Hum Genet 2000; 67: 1047-54.
86. Kuller JA, Cox VA, Schonberg SA, et al.
Pallister-Hall syndrome associated with an unbalanced chromosome
translocation. Am J Med Genet 1992; 43: 647-50.
87. Unsinn KM, Neu N, Krejci A, et al.
Pallister-Hall syndrome and McKusick-Kaufmann syndrome: one entity?
J Med Genet 1995; 32: 125-8.
88. Diaz LL, Grech KF, Prados MD. Hypothalamic
hamartoma associated with Laurence-Moon-Biedl syndrome. Case report
and review of the literature. Pediatr Neurosurg 1991; 17:
30-3.
89. Stephan MJ, Brooks KL, Moore DC, et al.
Hypothalamic hamartoma in oral-facial-digital syndrome type VI
(Varadi syndrome). Am J Med Genet 1994; 51: 131-6.
90. Sener RN. Cranial MR imaging findings in
Waardenburg syndrome: anophthalmia, and hypothalamic hamartoma.
Comput Med Imaging Graph 1998; 22: 409-11.
91. Slavotinek AM, Stone EM, Mykytyn K, et
al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat
Genet 2000; 26: 15-6.
92. Berkovic SF, Kuzniecky RI, Andermann F. Human
epileptogenesis and hypothalamic hamartomas: new lessons from an
experiment of nature. Epilepsia 1997; 38: 1-3.
|
CS
|
DPC
|
Morphological milestone
|